BioWorld

Oct. 16, 2000

View Archived Issues

Appointments and Advancements

Read More

Athersys Seeks $115M In IPO To Fund Functional Genomics

Read More

Ontogen Raises $16M In Series D To Advance Various Programs

Read More

Other News To Note

Read More

Correction

Read More

Recombinant Drug Saved Lives, Limbs Of Septic Shock Patients In Large Controlled Clinical Trial

Read More

Immunex Gains FDA Approval Of Novantrone As MS Therapy

Read More

Amgen's Second-Generation EPO Data Strong For Anemia

Read More